au.\*:("ROWLAND, M")
Results 1 to 25 of 188
Selection :
GIDE'S CORRESPONDENCE WITH EUGENE DABIT: THREE NEW LETTERSROWLAND M. L.ROMANCE NOTES. 1972, Vol 14, Num 2, pp 222-225Article
ANDRE GIDE'S TRIBUTE TO CHARLES-LOUIS PHILIPPE: SOME UNPUBLISHED CORRESPONDENCE (1910-1911)ROWLAND M. L.ROMANCE NOTES. 1971, Vol 13, Num 2, pp 204-210Article
The milliped genus Oriulus Chamberlin (Julida: Parajulidae)SHELLEY, Rowland M.Canadian journal of zoology. 2002, Vol 80, Num 1, pp 100-109, issn 0008-4301Article
The millipeds of central Canada (Arthropoda: Diplopoda), with reviews of the Canadian fauna and diplopod faunistic studiesSHELLEY, Rowland M.Canadian journal of zoology. 2002, Vol 80, Num 11, pp 1863-1875, issn 0008-4301, 13 p.Article
PLASMA PROTEIN BINDING AND THERAPEUTIC DRUG MONITORINGROWLAND M.1980; THER. DRUG MONIT.; USA; DA. 1980; VOL. 2; NO 1; PP. 29-37; BIBL. 34 REF.Article
Changes in the circadian flight activity of the mosquito Anopheles stephensi associated with insemination, blood-feeding, oviposition and nocturnal light intensityROWLAND, M.Physiological entomology. 1989, Vol 14, Num 1, pp 77-84, issn 0307-6962Article
Physiologic pharmacokinetic models and interanimal species scalingROWLAND, M.Pharmacology & therapeutics (Oxford). 1985, Vol 29, Num 1, pp 49-68, issn 0163-7258Article
FURTHER CONSIDERATIONS OF THE "SINGLE-POINT SINGLE-DOSE" METHOD TO ESTIMATE INDIVIDUAL MAINTENANCE DOSAGE REQUIREMENTSUNADKAT JD; ROWLAND M.1982; THER. DRUG MONIT.; ISSN 0163-4356; USA; DA. 1982; VOL. 4; NO 2; PP. 201-208; BIBL. 19 REF.Article
SYMBOLS IN PHARMACOKINETICSROWLAND M; TUCKER G.1980; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1980; VOL. 8; NO 5; PP. 497-507; BIBL. 8 REF.Article
HEPATIC CLEARANCE OF DRUGS. I. THEORETICAL CONSIDERATIONS OF A "WELL-STIRRED" MODEL AND A "PARALLEL TUBE" MODEL. INFLUENCE OF HEPATIC BLOOD FLOW, PLASMA AND BLOOD CELL BINDING, AND THE HEPATOCELLULAR ENZYMATIC ACTIVITY ON HEPATIC DRUG CLEARANCE.PANG KS; ROWLAND M.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 6; PP. 625-653; BIBL. 1 P. 1/2Article
USE OF IN VITRO DISSOLUTION DATA TO PREDICT PLASMA DRUG PROFILES.AARONS LJ; ROWLAND M.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 9; PP. 1359-1362; BIBL. 3 REF.Article
Bioavailability assessment and pharmacologic response: impact of first-pass loss when both drug and metabolites are activeROWLAND, M.Journal of pharmacokinetics and biopharmaceutics. 1988, Vol 16, Num 6, pp 573-593, issn 0090-466XArticle
ACCEPTABLE SAMPLING TIMES AT PLATEAU FOR DRUG ANALYSISROWLAND M; UNADKAT JD.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 5; PP. 687-689; BIBL. 2 REF.Article
HEPATIC CLEARANCE OF DRUGS. II. EXPERIMENTAL EVIDENCE FOR ACCEPTANCE OF THE "WELL STIRRED" MODEL OVER THE "PARALLEL TUBE" MODEL USING LIDOCAINE IN THE PERFUSED RAT LIVER IN SITU PREPARATION.PANG KS; ROWLAND M.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 6; PP. 655-680; BIBL. 28 REF.Article
Management of gamma HCH/dieldrin resistance in mosquitoes ― a strategy for all insects?ROWLAND, M.Brighton crop protection conference: pests and diseases. 1988, Vol 1, pp 495-500Conference Paper
Scheele lecture. Pharmacokinetics: concepts, insights and applicationsROWLAND, M.Acta pharmaceutica suecica. 1986, Vol 23, Num 3, pp 173-190, issn 0001-6675Article
KINETICS OF DRUG DISPLACEMENT INTERACTIONSAARONS LJ; ROWLAND M.1981; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1981; VOL. 9; NO 2; PP. 181-190; BIBL. 11 REF.Article
Clinical pharmacokinetics of teicoplaninROWLAND, M.Clinical pharmacokinetics. 1990, Vol 18, Num 3, pp 184-209, issn 0312-5963Article
Lafcadio's Crime RevisitedROWLAND, M.The French review. 1989, Vol 62, Num 4, pp 604-611, issn 0016-111XArticle
Current developments in pharmacokineticsROWLAND, M.Journal de pharmacie clinique (Paris). 1985, Vol 4, Num 3, pp 339-345, issn 0291-1981Article
SIMPLE METHOD FOR THE OPTIMISATION OF MOBILE PHASE COMPOSITION FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF A MULTI-COMPONENT MIXTURETOON S; ROWLAND M.1981; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1981; VOL. 208; NO 2; PP. 391-397; BIBL. 7 REF.Article
REFRACTION STATUS AND MOTILITY DEFECTS OF PERSONS 4-74 YEARS. UNITED STATES, 1971-1972ROBERTS J; ROWLAND M.1978; NATION. CENTRE HEALTH STATIST., 11; USA; DA. 1978; NO 206; 128 P.; BIBL. 15 REF.Serial Issue
HEPATIC CLEARANCE OF DRUGS. III. ADDITIONAL EXPERIMENTAL EVIDENCE SUPPORTING THE "WELL-STIRRED" MODEL, USING METABOLITE (MEGX) GENERATED FROM LIDOCAINE UNDER VARYING HEPATIC BLOOD FLOW RATES AND LINEAR CONDITIONS IN THE PERFUSED.PANG KS; ROWLAND M.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 6; PP. 681-699; BIBL. 14 REF.Article
ABSORPTION KINETICS OF A SERIES OF LOCAL ANESTHETICS FROM RAT SUBCUTANEOUS TISSUE. ILEVY RH; ROWLAND M.1974; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1974; VOL. 2; NO 4; PP. 313-335; BIBL. 12REF.Article
DETERMINATION OF THERMODYNAMIC DISSOCIATION CONSTANTS OF LOCAL ANESTHETIC AMINES: INFLUENCE OF IONIC STRENGTH = DETERMINATION DES CONSTANTES DE DISSOCIATION THERMODYNAMIQUE D'AMINES ANESTHESIQUES LOCALES: INFLUENCE DE LA FORCE IONIQUELEVY RH; ROWLAND M.1972; J. PHARM. PHARMACOL.; G.B.; DA. 1972; VOL. 24; NO 11; PP. 841-847; BIBL. 23REF.Serial Issue